Parathyroid hormone in osteoporosis.
Purdie
David W
DW
John Radcliffe Hospital Oxford OX3 9DU, UK.
Rees
Magaret
M
D000368:Aged; D015519:Bone Density / Q000187:drug effects; D016001:Confidence Intervals; D003720:Densitometry; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D005598:Fractures, Spontaneous / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007279:Injections, Subcutaneous; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000627:therapeutic use*; D012016:Reference Values; D012307:Risk Factors; D012720:Severity of Illness Index; D016103:Spinal Fractures / Q000188:drug therapy / Q000517:prevention & control*; D016896:Treatment Outcome; D006113:United Kingdom
C470125:PTH protein, human; D010281:Parathyroid Hormone